Skip to main content
PeptideSciences101NH2COOH
PeptideSciences101

Research-stage peptides

Research-stage profiles summarize available evidence and are not treatment recommendations. These compounds are not FDA-approved for human use; some are prescription-only or compounding-only.

These 74 peptides are studied primarily in laboratory, preclinical, or early clinical settings, or are handled through compounding rather than FDA approval. Every profile carries a regulatory status. An evidence grade appears once the profile and its linked sources have completed editorial review; until then the profile is labelled “Editorial review pending” rather than carrying a provisional grade. For approved drugs, see the FDA-approved list, or FDA-approved vs research-only for how the two compare.

A

  • ACE-031Editorial review pendingResearch-stage

    Myostatin inhibitor

  • ActoveginEditorial review pendingResearch-stage

    Hypoxic pain and healing

  • AMP-KEditorial review pendingResearch-stage

    Metabolic immune support

  • AOD-9604Editorial review pendingResearch-stage

    Fat loss, metabolic enhancement

  • ARA-290Editorial review pendingResearch-stage

    Neuropathic pain specialist

  • Argireline (Acetyl Hexapeptide-8)Editorial review pendingResearch-stage

    Botox-like peptide

B

  • Beta-Glucan PeptideEditorial review pendingResearch-stage

    Immune activating complex

  • BPC-157Editorial review pendingNot FDA-approved

    Healing & recovery, gut health

C

  • CagriSemaEditorial review pendingResearch-stage

    Combination therapy

  • CerebrolysinEditorial review pendingResearch-stage

    Neuroprotection, recovery

  • CJC-1295Editorial review pendingResearch-stage

    Growth hormone, muscle mass, fat loss

  • Collagen PeptidesEditorial review pendingResearch-stage

    Structural bone and joint support

  • CortagenEditorial review pendingResearch-stage

    Brain bioregulator

  • CortexinEditorial review pendingResearch-stage

    Neuropeptide complex

D

  • DHEA PeptideEditorial review requiredResearch-stage

    Hormone precursor support

  • DihexaEditorial review requiredNot FDA-approved

    Potent cognitive enhancer

  • DSIPEditorial review pendingNot FDA-approved

    Delta sleep-inducing peptide

E

F

G

  • GHK-CuEditorial review pendingNot FDA-approved

    Wound healing, skin regeneration

  • GhrelinomimeticEditorial review requiredResearch-stage

    Appetite and healing support

  • GHRP-4Editorial review pendingResearch-stage

    Fourth generation GHRP

  • GLOW StackEditorial review pendingResearch-stage

    Trending injectable research blend of GHK-Cu, BPC-157 and TB-500, marketed for skin rejuvenation and tissue recovery. Not FDA-approved; sold as a research chemical.

  • Glycine PeptideEditorial review requiredResearch-stage

    Sleep quality amino peptide

  • GroprinosinEditorial review pendingResearch-stage

    Antiviral immune booster

H

  • HCG (Human Chorionic Gonadotropin)Editorial review requiredResearch-stage

    Testosterone production support

  • Hexapeptide-11Editorial review pendingResearch-stage

    Cell renewal peptide

  • HexarelinEditorial review pendingResearch-stage

    Potent GH releaser

  • HumaninEditorial review pendingResearch-stage

    Mitochondrial protection, longevity

I

  • ImunofanEditorial review pendingResearch-stage

    Russian immune peptide

  • IpamorelinEditorial review pendingResearch-stage

    GH secretagogue, anti-aging

K

  • KisspeptinEditorial review pendingResearch-stage

    Reproductive hormone regulator

  • KPVEditorial review pendingNot FDA-approved

    Anti-inflammatory immune peptide

L

  • LarazotideEditorial review pendingResearch-stage

    Gut permeability regulator

  • LeptinEditorial review requiredResearch-stage

    Satiety hormone

  • LL-37Editorial review requiredNot FDA-approved

    Antimicrobial defense peptide

M

N

  • NA-Semax-AmidateEditorial review pendingNot FDA-approved

    Triple modified Semax

  • NSI-189Editorial review pendingResearch-stage

    Neurogenesis, depression

O

  • OvagenEditorial review pendingResearch-stage

    Digestive system bioregulator

P

R

  • RetatrutideEditorial review pendingInvestigational

    Investigational triple agonist (GIP/GLP-1/glucagon). TRIUMPH-1 Phase 3 (May 2026): 28.3% body weight loss at 80 weeks. FDA submission anticipated Q3–Q4 2026.

  • RG3 (Rhodiola)Editorial review pendingResearch-stage

    Adaptogenic peptide

S

  • SelankEditorial review requiredResearch-stage

    Anxiety reduction, focus

  • Selank-AmidateEditorial review pendingResearch-stage

    Extended release Selank

  • SemaxEditorial review requiredNot FDA-approved

    Cognitive enhancement, focus, memory

  • Semax Low DoseEditorial review pendingNot FDA-approved

    Evening cognitive calming

  • Semax-AmidateEditorial review pendingNot FDA-approved

    Extended release Semax

  • Snap-8Editorial review pendingResearch-stage

    Enhanced Argireline

  • SplenopentinEditorial review pendingResearch-stage

    Spleen-derived immune peptide

  • Syn-CollEditorial review pendingResearch-stage

    Collagen synthesis peptide

T

  • TB-500Editorial review requiredNot FDA-approved

    Tissue repair, flexibility, inflammation

  • TB4-FRAGEditorial review requiredResearch-stage

    TB-500 fragment

  • ThymalinEditorial review requiredResearch-stage

    Thymus restoration peptide

  • Thymosin Alpha-1Editorial review pendingResearch-stage

    Immune system support

  • Thymosin Beta-4Editorial review requiredNot FDA-approved

    Comprehensive tissue pain relief

  • ThyreogenEditorial review pendingResearch-stage

    Thyroid function support

U

  • Urolithin AEditorial review pendingResearch-stage

    Mitochondrial health compound

V

  • VilonEditorial review pendingResearch-stage

    Simple immune dipeptide

  • VladonixEditorial review pendingResearch-stage

    Thymus bioregulator complex

Y

  • YK-11Editorial review pendingResearch-stage

    Myostatin inhibitor